Medications

Dabigatran doesn't beat aspirin for preventing recurrent stroke

(HealthDay)—Dabigatran is not superior to aspirin for preventing recurrent stroke in patients with recent history of embolic stroke of undetermined source, according to a study published in the May 16 issue of the New England ...

Diseases, Conditions, Syndromes

Lower risk of gastrointestinal bleeding for apixaban

(HealthDay)—For patients receiving direct oral anticoagulant (DOAC) agents for non-valvular atrial fibrillation, apixaban is associated with a lower risk of gastrointestinal (GI) bleeding than rivaroxaban or dabigatran, ...

Diseases, Conditions, Syndromes

Lower risk of dabigatran-tied bleeding with gastroprotection

(HealthDay)—For patients taking dabigatran, the risk of gastrointestinal bleeding (GIB) is reduced with use of gastroprotective agents, according to a study published in the September issue of Gastroenterology.

Cardiology

Novel oral anticoagulant prescriptions soar, but at a high cost

Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid ...

page 1 from 2